About
Simulations Plus
SLP.US
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products.
Profile
- Company Name
- Simulations Plus, Inc.
- Market
- NasdaqGS
- Founded
- Industry
- --
- Fiscal Year End
- August 31
- Website
- www.simulations-plus.com